Correlation Between Medigen Vaccine and Level Biotechnology

Can any of the company-specific risk be diversified away by investing in both Medigen Vaccine and Level Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Vaccine and Level Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medigen Vaccine Biologics and Level Biotechnology, you can compare the effects of market volatilities on Medigen Vaccine and Level Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Vaccine with a short position of Level Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Vaccine and Level Biotechnology.

Diversification Opportunities for Medigen Vaccine and Level Biotechnology

0.69

Correlation Coefficient

Medigen Vaccine  Level Biotechnology

Poor diversification

The 3 months correlation between Medigen and Level is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Vaccine Biologics and Level Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Level Biotechnology and Medigen Vaccine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Vaccine Biologics are associated (or correlated) with Level Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Level Biotechnology has no effect on the direction of Medigen Vaccine i.e., Medigen Vaccine and Level Biotechnology go up and down completely randomly.

Pair Corralation between Medigen Vaccine and Level Biotechnology

Assuming the 90 days trading horizon Medigen Vaccine Biologics is expected to generate 4.59 times more return on investment than Level Biotechnology. However, Medigen Vaccine is 4.59 times more volatile than Level Biotechnology. It trades about 0.19 of its potential returns per unit of risk. Level Biotechnology is currently generating about 0.16 per unit of risk. If you would invest  3,715  in Medigen Vaccine Biologics on December 29, 2024 and sell it today you would earn a total of  1,495  from holding Medigen Vaccine Biologics or generate 40.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.25%
Values	Daily Returns

Medigen Vaccine Biologics  vs.  Level Biotechnology

Medigen Vaccine Biologics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Vaccine Biologics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.

Level Biotechnology

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Level Biotechnology are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Level Biotechnology may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Medigen Vaccine and Level Biotechnology

The main advantage of trading using opposite Medigen Vaccine and Level Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Vaccine position performs unexpectedly, Level Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Level Biotechnology will offset losses from the drop in Level Biotechnology's long position.

The idea behind Medigen Vaccine Biologics and Level Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.